ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 20909 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 20909; 2) Community: the network communities that were significantly associated with the response to NSC 20909; 3) Molecule: the relationships between components within communities and NSC 20909; 4) MDR: the compounds that were significantly associated with the NSC 20909.

NSC Compound Enrichment Correlation
NSC 713608 Null 0.0283958753782624 0.56274805
NSC 722222 Null 0.0283958753782624 0.50578569
NSC 724631 4,11-dihydroxy-1-[4-[[2-hydroxy-1-(hydroxymethyl)-1-methylet hyl]-mino]butyl]-1H-naphtho[2,3-f]indole-5,10-dione 0.0283958753782624 0.33958312
NSC 730563 Miliusane A 0.0283958753782624 0.15090747
NSC 734977 Ethyl N-[4-(10-methyl-3-phenyl-4H-indolo[3,2-e][1,2,3]triazolo [1,5-a]pyrimidin-4-yl)butanoyl]glycinate 0.0283958753782624 0.043516868
NSC 747452 3,19-(4-Acetamido)benzylidineandrographolide 0.0283958753782624 0.36333324
NSC 749292 3-methoxy-1-nitrosopyrido[3,2:4,5]pyrrolo[1,2-c][1,2,3]benzotriazine 0.0283958753782624 0.27964702
NSC 749379 Null 0.0283958753782624 0.47446749
NSC 749550 3-amino-N-(4-benzylphenyl)-5-chloro-1H-indazole-1-carboxamide 0.0283958753782624 0.16856572
NSC 763646 (E)-2-(2-(benzo[d][1,3]dioxol-5-yl)vinyl)-5-(3-methyl-1H-pyrazol-5-yl)-1,3,4-oxadiazole 0.0283958753782624 0.34295041
Total:117  Current:73    [First] [Prev] [Next] [Last]